Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

Example Input: Paragraph: A nurse prepares a bottle of donated milk for a baby at Son Dureta's Hospital in Palma de Mallorca, Spain March 10, 2006. REUTERS/Dani Cardona The chemical bisphenol A, or BPA, is commonly used in plastic food and beverage containers and in the coating of food cans. Until now, environmental and consumer activists who have questioned the safety of BPA have relied on animal studies. But the study by British researchers in the Journal of the American Medical Association found that among 1,455 U.S. adults, those with the highest levels of BPA were more likely to have heart disease, diabetes and liver-enzyme abnormalities than those with the lowest levels. U.S. Food and Drug Administration officials said they would review the new findings, which were not yet published when the agency issued a draft conclusion in August that BPA is safe at current exposure levels. “We have confidence in the data that we’ve looked at and the data that we’re relying on to say that the margin of safety is adequate,” FDA official Laura Tarantino said at a meeting of experts advising the agency on whether it made the right call. “There are things you can do if you choose to reduce your level of bisphenol A,” Tarantino said. “But we have not recommended that anyone change their habits or change their use of any of these products because right now we don’t have the evidence in front of us to suggest that people need to.”   Panel chairman Martin Philbert declined to say what the committee’s next move would be. BPA is used to make polycarbonate plastic, a clear shatter-resistant material in products ranging from baby bottles to medical devices. BPA can mimic the hormone estrogen in the body. People can consume BPA when it leaches out of the plastic into baby formula, water or food inside a container. Some retailers and manufacturers are moving away from products with BPA. Canadian officials have concluded BPA was harmful. Steven Hentges of the American Chemistry Council, an industry group, said the study’s design did not allow for anyone to conclude BPA causes heart disease and diabetes. “On the other hand, though, bisphenol A has been very intensively studied in a very large number of laboratory animal studies. And the weight of evidence from those studies ... continues to support the safe use of products containing bisphenol A,” he said in a telephone interview. The British researchers, who acknowledged their findings are not proof that the chemical is causing the harm, analyzed urine samples from a U.S. government health survey of adults ages 18-74 representative of the U.S. population. The 25 percent of people with the highest levels of bisphenol A in their bodies were more than twice as likely to have heart disease, including heart attacks or type 2 diabetes, compared to the 25 percent with the lowest levels. At the FDA panel meeting, several scientists and activists said the FDA ignored animal studies finding health concerns and some called for the chemical to be banned in food containers. Democratic U.S. Rep. John Dingell of Michigan, who heads the House Committee on Energy and Commerce, said the FDA has “focused myopically on industry-funded research.”   Iowa Republican Sen. Chuck Grassley, ranking member of the Committee on Finance, released a letter he wrote to FDA Commissioner Dr. Andrew von Eschenbach asking why the agency has not appointed a safety panel to review BPA. Tarantino said nothing was ignored but industry-funded studies finding no harm were important in the conclusions. The panel is expected to present its advice to the FDA next month. Tarantino, head of the FDA’s office of food additive safety, said there is talk of government scientists doing their own BPA safety studies, but that could take years to conduct. Claim: Common plastics chemical linked to heart problems.
Example Output: A major study links a chemical widely used in plastic products, including baby bottles, to health problems in humans like heart disease and diabetes, but U.S. regulators said on Tuesday they still believe it is safe.

Example Input: Paragraph: "Accusations about the responsible party behind the United States’ struggle to accelerate coronavirus testing have come from every which way and the blame has fallen, often inaccurately, on the shoulders of different public officials. In a March 13 tweet, President Donald Trump said the Centers for Disease Control and Prevention studied its testing system for decades but wasn’t prepared for a large scale pandemic, an issue that was complicated by policy changes made by former President Barack Obama. U.S. Sen. Chuck Schumer, D-N.Y., retweeted Trump’s remark and added his own comment: ""Trump is once again trying to blame the previous administration for the number of tests available. This is his #DailyLie."" U.S. Rep. Dan Crenshaw, R-Houston, retweeted Schumer’s remark and said: ""It’s not Obama’s fault and it’s not Trump’s fault. We have stringent FDA regulations, long in place, that created barriers to the private industry creating a test quickly."" PolitiFact looked at a different Trump claim blaming Obama for a lack of testing. We also looked at a claim from Democrat Joe Biden about the Trump administration rejecting tests from the World Health Organization (they were never offered). Trump also inaccurately stated that any individual who wants to be tested for the coronavirus can get a test. We wanted to dig deeper into Crenshaw’s claim, which attributes the delays in the availability of widespread testing to Food and Drug Administration regulations. Justin Discigil, spokesman for Crenshaw, pointed to articles from ProPublica, the New Yorker, The Atlantic and the Washington Post, all of which highlighted the role FDA regulations played here. He added: ""Just to be clear – nowhere did we say that these regulations were the sole/only reason for the testing issue, we said that they created barriers."" A timeline of events The first confirmed case of COVID-19 in the United States came at the end of January, when a man in Washington state developed symptoms after returning from a trip to Wuhan. One month later, federal health officials at the Centers for Disease Control and Prevention said it was inevitable that the U.S. would experience a spread of the virus and urged people to take precautions. In these early days of the virus, tests were not widely distributed to local and state laboratories. Instead, testing for the new coronavirus was conducted almost entirely by the CDC — samples collected at the local level were sent to the agency. Initial test kits developed by the CDC for use in local and state labs were flawed and produced inaccurate results in some labs, meaning they couldn’t be distributed. As the agency worked to correct the tests, health officials turned to the FDA. The U.S. Association of Public Health Laboratories submitted a letter asking the agency to use ""enforcement discretion"" and authorize local and state labs to develop and use their own tests. During a public health emergency, labs and drug manufacturers must seek an Emergency Use Authorization from the FDA to use diagnostic tests and medical treatments that have not gone through the typical clearance process — to share them faster in the emergency. (These authorizations were begun in 2004 under President George W. Bush.) For laboratory-developed tests, like the ones in question, FDA policy has stated that they cannot be used in clinical diagnoses without the FDA’s approval during an emergency. Although the goal of these regulations is to ensure only accurate lab tests are conducted, health officials have said they prevented them from quickly responding to the virus. One doctor in a Seattle lab described the process for getting an Emergency Use Authorization from the FDA and said the agency asked for a level of testing that didn’t make sense in the context of an emergency, according to a GQ profile. A doctor in North Carolina told NBC News that she had developed a test using the World Health Organization’s protocol but had yet to receive the use authorization from the FDA, putting the state ""way behind"" in its ability to test patients. On Feb. 29, the FDA announced a change in the process: Labs would still need to seek the agency’s approval for their tests, but the labs could begin testing while waiting for the official green light. On March 16, (three days after Crenshaw made his claim) the FDA announced another change to its policies and put state officials in charge of coronavirus tests developed by laboratories in their states, meaning labs would engage with state officials and not the FDA. It also removes the requirement for these labs to apply for an Emergency Use Authorization for their tests. The changes also expand which labs and manufacturers are included in FDA guidelines and which kinds of tests can be developed. ""We believe the unprecedented policy set forth in today’s updated guidance, which addresses laboratories and commercial manufacturers, will help address these urgent public health concerns by helping to expand the number and variety of diagnostic tests, as well as available testing capabilities in health care settings, and reference and commercial laboratories,"" reads a release from the agency. After the changes After the FDA announced changes to its policies, Labcorps and Quest Diagnostics both announced plans to start testing for the new coronavirus, crediting changes in federal policy with their ability to do so. ""We applaud the FDA for providing the flexibility for innovative, quality lab developed tests to be brought to patients and providers quickly to advance effective response to the coronavirus outbreak,"" said Steve Rusckowski, chairman and chief executive officer of Quest Diagnostics, in a statement. But even as state and local authorities move to ramp up testing, the number of available tests is still lacking. In Austin, for example, there is still a gap between available test kids and demand for testing, as officials prioritize testing for health care workers, people living in nursing homes and people at high risk for complications from the virus. Our Ruling Crenshaw said in a tweet that longstanding FDA regulations ""created barriers to the private industry creating a test quickly"" for the coronavirus. Crenshaw’s statement is accurate. FDA procedures adopted in 2004 meant laboratories had to seek the agency’s approval before developing and using tests in communities, a policy many health care officials have said prevented the country from taking early action in response to the novel coronavirus. It is important to keep in mind that other factors have contributed to the low levels of testing for the virus, beyond the FDA regulations. But Crenshaw’s statement is accurate." Claim: Dan Crenshaw Says longstanding Food and Drug Administration regulations “created barriers to the private industry creating a test quickly” for the coronavirus.
Example Output: Food and Drug Administration regulations in place since 2004 require labaratories to get an Emergency Use Authorization from the agency to use diagnostic tests and medical treatments that haven't gone through the typical clearance process. The policy was intended to speed up the process, but researchers reported significant delays between seeking an application and getting approval and these regulations played a role in that. The FDA has since changed the regulations to allow labs to start utilizing tests before receiving clearance.

Example Input: Paragraph: Exploring online was easy, with hashtags like #scars, #hurt and #brokeninside. Nothing made sense back then, but Theo absorbed what he saw on websites like a religion. All he could focus on was how the exterior he was born with — that of a girl — didn’t look or feel right. That was six years ago, when he had another name and a different gender. Back then, Theo felt that his body was rebelling in disturbing ways. He developed breasts and got his period. He felt like a boy, but every month, the cramps reminded him of reality. He became a child at war with his body. He wasn’t aware of words like gender dysphoria or transgender; those would come later. So would the national debates, the furor over bathrooms, and discussions of how to help children who didn’t feel right in their own skin. “When you’re 10 years old, you really shouldn’t be worried about who you are,” Theo would say years later, in a moment of reflection. “You shouldn’t be having that existential question when you’re in fifth grade. You should be worried about homework and the fifth-grade dance coming up.” He knew he was different from other kids in class. One day in the girls’ bathroom at his South Florida elementary school, Theo made the first of many gouges in his arm, using a paperclip. Pricks of blood bloomed on his fair skin. A teacher and a school nurse whisked Theo to safety. Theo’s mother, Lori Ramos, got the call from the principal. Her child was in the hospital. Ramos burst into the ER: Was it a fall, a fight, a shooting? “What’s going on here?” Ramos demanded of doctors and school staff. The answers were confusing: Her child had asked a teacher to call her by a different name, use different pronouns. Her child didn’t feel normal and wanted to be a boy. Ramos was bewildered — she saw no prior clues her child felt this way. And she was no stranger to transgender, gay, lesbian and bisexual issues — she worked in a clinic for HIV patients. When she’d given birth in 2001, in a hot tub on the family’s back porch in a Florida suburb an hour south of glitzy Miami Beach, she was thrilled. “I had my older son, and I had my girl, and my family was complete,” Ramos said. Her baby. Her “sunshine girl.” One who was no longer filled with light. Theo was involuntarily committed for 72 hours so doctors could determine whether he was a danger to himself or others. Soon, therapists and doctors had a diagnosis: gender dysphoria, a conflict between a person’s physical or assigned gender and the gender with which they identify. But a diagnosis didn’t solve Theo’s problems or make him feel better. When he tried to look like a boy, everyone at school noticed. His mother was accepting; his father wasn’t. He threatened to disown Theo. Theo again turned to the internet. He started cutting around his thighs and hips — his “problem areas.” When Theo saw thin kids online, he looked at his own baby fat and, once again, didn’t fit in. He wouldn’t eat for days, or he’d force himself to throw up. Cutting and vomiting weren’t painful, not exactly. They were more of a stress release, a way to match physical pain to what he felt inside: “I just know that it isn’t right, that the body I have isn’t supposed to be this way.” Small aggressions at school led to outright bullying. Other kids asked what was in Theo’s pants, if he had a penis, if he could show them. Theo started missing school. A therapist diagnosed depression and anxiety disorder. If only Theo could become a boy through hormone therapy — that, he thought, would solve his problems. “It’s just like every time I’m misgendered it feels like a wrench clamping around my heart and it slowly grows tighter and tighter,” he explained. “Being addressed as female or identifying as female never felt right to me; it always gave me this acute sense of discomfort and pain.” Hormone therapy for transgender children is a recent, controversial practice. It hasn’t been studied much. The concept that children can be transgender has been discussed in the open only recently; previously, it was something to be hidden, squashed and ignored. About 150,000 teenagers in the U.S. identify as transgender, according to a 2017 study by the Williams Institute at UCLA’s School of Law. About 1.4 million U.S. adults identify as transgender. Medical professionals have come up with protocols for children and teens. They recommend that some kids with gender dysphoria essentially pause puberty with hormone blockers until they’re certain they want to live as a different gender. But the child must be prepubescent. It was too late when Theo and his parents learned about the option. Theo could take testosterone, but rigorous counseling sessions were recommended first. This annoyed Theo: Why not become a boy right away? Experts say impatience is common: Transgender children want to transition, and waiting is frustrating. Even under regular circumstances, teens and patience aren’t usually mentioned in the same sentence. Doctors say going slow when treating trans teens is essential for physical and emotional well-being, and note that if a teen’s feelings last until age 16, the desires are probably permanent. Theo insisted testosterone could bring peace with his body: “If I could just start T therapy, I would know I was on the way to being who I’m supposed to be.” His parents, though, worried about the effects on their growing child. Theo wanted testosterone, but his anxiety sometimes made him question his desires. It became a regular topic of conversation between mother and son. “I’m nervous,” Theo said in the spring of 2016. He was 14. “What if I do change my mind?” “Well, what if you do?” asked his mother. “I can always stop,” Theo said. Ramos shook her head. “The changes are permanent.” ____ EDITOR’S NOTE: The Associated Press followed Theo Ramos for more than a year as he grappled with his gender dysphoria. This is the first installment of a three-part story. PART ONE: As a child grappling with gender dysphoria, Theo Ramos found himself at war with his body. PART TWO, coming Tuesday: Living with a transitioning transgender child “is anything but a straight line,” as his mom says. PART THREE, coming Wednesday: Visibility of transgender issues is at a high, but all the talk in the world doesn’t make life any easier as a gender-fluid or transitioning kid. ____ Follow Tamara Lush on Twitter at https://twitter.com/tamaralush . Claim: Trans teen’s war with his body started when he was just 10.
Example Output:
Theo Ramos learned how to cut himself when he was in fifth grade, when his body seemed to revolt.